These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7695469)

  • 1. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXV: Interactions of the oligoamine RE 1492 with biomembranes.
    Kesselhut A; Ebel H; von Bruchhausen F; Rehse K
    Arch Pharm (Weinheim); 1995 Jan; 328(1):21-7. PubMed ID: 7695469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIII: Influence of the oligoamine RE 1492 on the deformability of red blood cells.
    Neumann M; Müller S; Grosse J; Lerche D; Rehse K
    Arch Pharm (Weinheim); 1994 Aug; 327(8):497-501. PubMed ID: 7944905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVI: Antiplatelet and antithrombotic effects of the oligoamine RE 1492 in combination with standard and future antithrombotic drugs.
    Rehse K; Ciborski T
    Arch Pharm (Weinheim); 1995 Apr; 328(4):333-7. PubMed ID: 7611829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVII: Oligoamines with fluorescent properties. Part A: Fluorescent bridged nitrogen functions.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1992 Apr; 325(4):235-9. PubMed ID: 1530456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aggregation inhibiting and anticoagulant effects of oligoamines. 13. Improvement in the storage of whole blood and erythrocyte suspensions with oligoamines].
    Rehse K; Kaehler H; Kuberka H
    Arch Pharm (Weinheim); 1990 Aug; 323(8):475-9. PubMed ID: 2278513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIX: Influence of the antithrombotic oligoamine RE 1492 on the storage of red blood cells, morphology, their potassium and ATP content, hemolysis and viability.
    Rehse K; Müller S
    Arch Pharm (Weinheim); 1995 Apr; 328(4):339-42. PubMed ID: 7611830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVII. Inhibition of leucocyte adherence to endothelium by the oligoamine RE 1492C and the NO-donor RE 2047.
    Rehse K; Ciborski T; Müller B
    Arch Pharm (Weinheim); 1995 Feb; 328(2):125-6. PubMed ID: 7726736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVI: Cytostatic and cytotoxic side effects of oligoamines.
    Rehse K; Noack B; Maurer R; Hilgard P
    Arch Pharm (Weinheim); 1991 Oct; 324(10):797-801. PubMed ID: 1805711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVIII: Oligoamines with fluorescent properties. Part C: Fluorescent oligoamines with enhanced hydrophilic properties.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1995 Feb; 328(2):131-5. PubMed ID: 7726738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIV: Branched aliphatic and alicyclic triamines and tetramines.
    Rehse K; Kesselhut A; Schein V; Leissring S
    Arch Pharm (Weinheim); 1991 Apr; 324(4):243-7. PubMed ID: 1863203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVIII: Oligoamines with fluorescent properties, Part B: Fluorophores in the molecular periphery.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1994 Jun; 327(6):399-404. PubMed ID: 8048847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XX: 4,4',4''-(1,3,5)-benzene-tris-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Apr; 326(4):217-9. PubMed ID: 8494483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XV: Antithrombotic effect of selected oligoamines in rats.
    Rehse K; Kesselhut A; Schein V; Kämpfe M; Rose B; Unsöld E
    Arch Pharm (Weinheim); 1991 May; 324(5):301-5. PubMed ID: 1888267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXII: Bisoxazol-, bisimidazol-, bisthiazol- and oligo-1,2,4-thiadiazolimines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Jul; 326(7):399-404. PubMed ID: 8357302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamines inhibit both platelet aggregation and glycoprotein IIb/IIIa activation.
    Corona-de-la-Peña N; Uribe-Carvajal S; Barrientos-Rios R; Matias-Aguilar L; Montiel-Manzano G; Majluf-Cruz A
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):216-21. PubMed ID: 16044034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXI: 4,4'-Alkylene-bis-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 May; 326(5):307-11. PubMed ID: 8328885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies with the stabilized epoprostenol analogue taprostene. Effect on platelets and erythrocytes.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Jul; 40(7):817-22. PubMed ID: 2222558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXX: Absorption, organ distribution, and excretion of the oligoamine (+)-(S,S)-1,4-bis-[4-(3-iodo-4-methoxyphenyl)-butylamino]-butane-2,3-di ol and its metabolites.
    Rehse K; Wolf S; Wenzel M
    Arch Pharm (Weinheim); 1995 May; 328(5):465-7. PubMed ID: 7611842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIX: 4,4'-Phenylene-bis-sydnone imines.
    Rehse K; Kämpfe M; Martens A
    Arch Pharm (Weinheim); 1993 Mar; 326(3):163-6. PubMed ID: 8481095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol effect on the physical state of lipid multibilayers from the platelet plasma membrane by time-resolved fluorescence.
    Vélez M; Lillo MP; Acuña AU; González-Rodríguez J
    Biochim Biophys Acta; 1995 May; 1235(2):343-50. PubMed ID: 7756344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.